Invion Limited announced that Craig Newton will retire as MD & CEO, for personal reasons, effective 31 October 2020. It is anticipated Chairman, Thian Chew, will become executive chairman and interim CEO from that time. Craig joined the Company in 2018 as Chief Operating Officer and was appointed MD and CEO on 1 November 2019. Craig has led strategic development of the Company, including a team of internal and external R&D experts and introduced high-calibre clinicians and key opinion leaders to the use of Photodynamic therapy in a range of cancers, setting the Company up for future success.